US Patent Issued to MYELOID THERAPEUTICS on March 18 for "Therapeutic cell compositions and methods of manufacturing and use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,545, issued on March 18, was assigned to MYELOID THERAPEUTICS INC. (Cambridge, Mass.).

"Therapeutic cell compositions and methods of manufacturing and use thereof" was invented by Daniel Getts (Stow, Mass.) and Yuxiao Wang (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions and methods for making and using engineered killer phagocytic cells for immunotherapy in cancer or infection by expressing a chimeric antigen receptor having an enhanced phagocytic activity, the chimeric receptor is encoded by a recombinant nucleic acid."

The patent was filed on March 15, 2021, under Application No. 17/202...